Considering the patents product/process of CTPR, seems many competitors are entering the fray and prices may go down considerably. They may not correct 90/95 as in US, but they will certainly correct as the product has gone off patent
Even if we assume 2000cr as conservatives estimates for CTPR, it is to be premium product. Once the prices correct, then number of players will eye market share. Will know soon, but looks 100-200 cr sales for Natco would not be a bad outcome.
| Subscribe To Our Free Newsletter |
